Oral Lesions in HIV/AIDS Patients on a highly Active Antiretroviral Therapy
Almas Binnal, TS Bastian
Citation Information :
Binnal A, Bastian T. Oral Lesions in HIV/AIDS Patients on a highly Active Antiretroviral Therapy. World J Dent 2016; 7 (2):95-99.
Oral lesions have been reported to be the initial signs of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) infection. The main objective of the present study was to observe the prevalence of oral lesions among HIV/AIDS patients undergoing highly active antiretroviral therapy (HAART) attending the antiretroviral therapy (ART) center in Kasturba Medical College and Hospital, Mangalore, Dakshina Kannada, Karnataka, India.
Materials and methods
One hundred and eight HIV/AIDS positive patients were evaluated by a single examiner. Patients’ oral cavity was examined and the various oral manifestations detected were recorded.
Results
The most common extraoral manifestation was lipoatrophy, and intraorally, the most prevalent findings were intraoral pigmentation (42.6%) and candidiasis (27.8%). However, the prevalence of the most commonly associated lesions like Kaposi's sarcoma (1.9%) and linear gingival erythema (2.7%) was less.
Conclusion
Oral lesions are considered to be markers of progression of HIV into the final stage of AIDS. Advent of HAART has shown a significant reduction in the oral lesions and a better quality of life in patients with HIV.
How to cite this article
Denny CE, Ramapuram J, Bastian TS, Ongole R, Binnal A, Natarajan S, Ahmed J. Oral Lesions in HIV/AIDS Patients on a highly Active Antiretroviral Therapy. Word J Dent 2016;7(2):95-99.
Laboratory Guidelines for enumerating CD4 T lymphocytes in the context of HIV/AIDS; 2007.
Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 2011 Sep;1(1):a006841.
HIV infection in India: epidemiology, molecular epidemiology and pathogenesis. J Biosci 2008 Nov;33(4):515-525.
Global report: UNAIDS report on the global AIDS epidemic 2010 [Internet]. Geneva: UNAIDS; 2010. [cited 2012 Sep 18]. Available from: http://www.unaids.org/documents/20101123_globalreport_em.pdf.
Available from: http://www/UNAIDS.org/.
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006 Sep;43(1):27-34.
Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 2005 Sep;83(9):700-706.
Effects of long-term use of HAART on oral health status of HIV-infected subjects. J Oral Pathol Med 2010 May;39(5):397-406.
Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal 2006 Jan 1;11(1):E33-E39.
Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci 2011 Jun;53(2):203-211.
Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000 May;6(3):152-157.
Oral manifestations of AIDS in a heterosexual population in a Zaire hospital. J Oral Pathol Med 1990 May;19(5):232-234.
Oral manifestations of HIV patients in South Indian population. J Pharm Bioallied Sci 2012 Aug;4(Suppl 2):S364-S368.
Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in Northern and Southern Thai. Oral Dis 2004 May;10(3):138-144.
Pathogenesis and treatment of lipodystrophy: what clinicians need to know. Top HIV Med 2008 Oct-Nov; 16(4):127-133.
Factors associated with the development of HIV associated lipodystrophy in patients on long-term HAART. Acad J 2012 Dec;5(12):448-454.
HIV-associated lipodystrophy – a new metabolic syndrome. Br J Diabetes Vasc Dis 2008; 8:129-134.
Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy. AIDS Rev 2012 Apr-Jun;14(2):112-123.
Lipodystrophy and dyslipidemia among patients taking first-line World Health Organization-recommended highly active antiretroviral therapy regimens in Western India. J Acquir Immune Defic Syndr 2005 Jun;39(2):199-202.
Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol 1998 Oct;134(10):1216-1220.
HIV/AIDS and blindness. Bull World Health Organ 2001 Feb;79(3):208-213.
Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006 Nov;12(6):537-542.
Cutaneous manifestations of HIV – a detailed study of morphological variants, markers of advanced disease, and the changing spectrum. Med J Armed Forces India 2012 Jan;68(1):20-27.
Prevalence of HIVassociated periodontitis and gingivitis in HIV-infected patients attending an AIDS clinic. J Acquir Immune Defic Syndr 1992; 5(5):479-483.
HIV-associated oral lesions in HIVseropositive patients at an HIV-treatment clinic in South Africa. J AIDS Clin Res 2015 Jan;6(422):3-11.
Risk factors for oral hairy leukoplakia in HIVinfected adults of Brazil. J Oral Pathol Med 2006 Jul; 35(6):321-326.
Incidence of oral hairy leukoplakia in human immunodeficiency virus-seropositive adult patients in Yunnan, China. Hua Xi Kou Qiang Yi Xue Za Zhi 2011 Apr;29(2):149-152.
Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV infected individuals and progression to Kaposi's sarcoma. Lancet 1995 Sep 23;346(8978):799-802.
AIDS related Kaposi's sarcoma presenting with palatal and eyelid nodule. J Assoc Physicians India 2012 Jul;60:50-53.
Oral Kaposi's sarcoma in HIV positive patients. A case report and a review of literature. J AIDS Clin Res 2014 Sep;5:349.
Ranula: another HIV/AIDS associated oral lesion in Zimbabwe? Oral Dis 2004 Jul; 10(4):229-232.
Oral ranula in an HIV-positive patient: case report and literature review. BMJ Case Rep 2012. Epub 2012 Jul10.
Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil. J Public Health Dent 2008 Summer; 68(3):178-181.
